Search research articles
Contact Us
Filters
Showing results (341-350 of 481) with videos related to
Page
of 49
Sort By:
Transplantation and Cellular Therapy
|
July 2, 2023
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure
Elizabeth M Holland, Bonnie Yates, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Clinical and molecular responses in lung cancer patients receiving Romidepsin
David S Schrump, Maria R Fischette, Dao M Nguyen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients
Claude Sportès, Nicole J McCarthy, Frances Hakim, et al.
Leukemia & Lymphoma
|
September 30, 2014
Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method
Elisabet E Manasanch, Dalia A Salem, Constance M Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2016
Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer
L Tiffany Lyle, Paul R Lockman, Chris E Adkins, et al.
Oncotarget
|
October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
Gideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.
The Oncologist
|
March 11, 2022
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
Cecilia Monge, Erica C Pehrsson, Changqing Xie, et al.
Frontiers in Oncology
|
June 18, 2015
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer
Jung-Min Lee, Jane B Trepel, Peter Choyke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2004
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia
James L Mulshine, Jane C Atkinson, Robert O Greer, et al.
Molecular Cancer Research : MCR
|
September 3, 2009
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis
Diane Palmieri, Daniel Fitzgerald, S Martin Shreeve, et al.
Page
of 49
Search research articles
Search
Showing results (341-350 of 481) with videos related to
Sort By:
Page
of 49
Transplantation and Cellular Therapy
|
July 2, 2023
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure
Elizabeth M Holland, Bonnie Yates, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Clinical and molecular responses in lung cancer patients receiving Romidepsin
David S Schrump, Maria R Fischette, Dao M Nguyen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients
Claude Sportès, Nicole J McCarthy, Frances Hakim, et al.
Leukemia & Lymphoma
|
September 30, 2014
Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method
Elisabet E Manasanch, Dalia A Salem, Constance M Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2016
Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer
L Tiffany Lyle, Paul R Lockman, Chris E Adkins, et al.
Oncotarget
|
October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
Gideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.
The Oncologist
|
March 11, 2022
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
Cecilia Monge, Erica C Pehrsson, Changqing Xie, et al.
Frontiers in Oncology
|
June 18, 2015
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer
Jung-Min Lee, Jane B Trepel, Peter Choyke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2004
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia
James L Mulshine, Jane C Atkinson, Robert O Greer, et al.
Molecular Cancer Research : MCR
|
September 3, 2009
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis
Diane Palmieri, Daniel Fitzgerald, S Martin Shreeve, et al.
Page
of 49